Private company

Venrock Healthcare Capital Partners II, L.P.

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Venrock Healthcare Capital Partners II, L.P. sits at the top of its group. 26 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Venrock Healthcare Capital Partners II, L.P. DE
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- Akouos, Inc. Stake · Boston, Massachusetts
- Altimmune, Inc. Stake · Gaithersburg, Maryland, United States
- Annexon, Inc. Stake · Brisbane, California
- aTyr Pharma Stake · San Diego, California, United States
- Axsome Therapeutics Stake · New York, New York, United States
- Celcuity Inc. Stake · Minneapolis, Minnesota, United States
- Cogent Biosciences, Inc. Stake · Waltham, Massachusetts
- Corvus Pharmaceuticals, Inc. Stake · Burlingame, California, United States
- DBV Technologies Stake · Chatillon, France
- GH Research PLC Stake · L2
- Inozyme Pharma, Inc. Stake · Boston, Massachusetts
- Instil Bio, Inc. Stake · Dover, Delaware, United States
- LeonaBio, Inc. Stake · Bothell, Washington
- LianBio Stake · Princeton, New Jersey
- Lyra Therapeutics, Inc. Stake · Watertown, Massachusetts
- Marinus Pharmaceuticals (United States) Stake · Radnor
- Provention Bio, Inc. Stake · Lebanon, New Jersey, United States
- RELMADA THERAPEUTICS, INC. Stake · New York, New York, United States
- Savara Inc Stake · Austin, Texas
- Sierra Oncology, Inc. Stake · San Mateo, California
- Trevi Therapeutics, Inc. Stake · New Haven, Connecticut
- Tricida Stake · San Francisco, California, United States
- Vistagen Therapeutics, Inc. Stake · South San Francisco, California
- Whitehawk Therapeutics, Inc. Stake · Cincinnati, Ohio, United States

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (25 companies). Each entity in the chart links to its source.

Stakes it holds

Venrock Healthcare Capital Partners II, L.P. has told the SEC it owns more than 5% of 25 companies, latest first (Schedules 13D and 13G).

DBV TechnologiesSCHEDULE 13G/A Jun 23, 2022 to Feb 17, 2026²
Cogent Biosciences, Inc.SCHEDULE 13G/A Feb 14, 2022 to Aug 14, 2025³
Trevi Therapeutics, Inc.SCHEDULE 13G/A Apr 21, 2022 to Feb 14, 2025⁴
Instil Bio, Inc.SC 13G/A Nov 14, 2024⁵
Lyra Therapeutics, Inc.SC 13G/A Apr 22, 2022 to Nov 14, 2024⁶
Aclaris Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2024⁷
Annexon, Inc.SC 13G/A Jun 23, 2022 to Feb 14, 2024⁸
GH Research PLCSC 13G/A May 27, 2022 to Feb 14, 2024⁹
Inozyme Pharma, Inc.SC 13G/A Apr 29, 2022 to Feb 14, 2024¹⁰
Savara IncSC 13G/A Feb 14, 2023 to Feb 14, 2024¹¹
Axsome TherapeuticsSC 13G/A Feb 14, 2023¹²
Celcuity Inc.SC 13G/A May 25, 2022 to Feb 14, 2023¹³
LianBioSC 13G/A Nov 10, 2021 to Feb 14, 2023¹⁴
Marinus Pharmaceuticals (United States)SC 13G/A Feb 14, 2022 to Feb 14, 2023¹⁵
Provention Bio, Inc.SC 13G/A Feb 14, 2023¹⁶
aTyr PharmaSC 13G/A Feb 14, 2022 to Feb 14, 2023¹⁷
TricidaSC 13G/A Feb 14, 2022 to Oct 28, 2022¹⁸
Vistagen Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Jul 8, 2022¹⁹
Akouos, Inc.SC 13G May 23, 2022²⁰
Altimmune, Inc.SC 13G/A Feb 14, 2022²¹
Corvus Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022²²
LeonaBio, Inc.SC 13G/A Feb 14, 2022²³
RELMADA THERAPEUTICS, INC.SC 13G Feb 14, 2022²⁴
Sierra Oncology, Inc.SC 13G/A Feb 14, 2022²⁵
Whitehawk Therapeutics, Inc.SC 13G Feb 14, 2022²⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVenrock Healthcare Capital Partners II, L.P. filings on SEC EDGAR
2
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SCHEDULE 13G/A on DBV Technologies
3
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SCHEDULE 13G/A on Cogent Biosciences, Inc.
4
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SCHEDULE 13G/A on Trevi Therapeutics, Inc.
5
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Instil Bio, Inc.
6
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Lyra Therapeutics, Inc.
7
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Aclaris Therapeutics, Inc.
8
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Annexon, Inc.
9
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on GH Research PLC
10
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Inozyme Pharma, Inc.
11
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Savara Inc
12
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Axsome Therapeutics
13
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Celcuity Inc.
14
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on LianBio
15
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Marinus Pharmaceuticals (United States)
16
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Provention Bio, Inc.
17
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on aTyr Pharma
18
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Tricida
19
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Vistagen Therapeutics, Inc.
20
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G on Akouos, Inc.
21
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Altimmune, Inc.
22
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Corvus Pharmaceuticals, Inc.
23
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on LeonaBio, Inc.
24
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G on RELMADA THERAPEUTICS, INC.
25
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G/A on Sierra Oncology, Inc.
26
SEC EDGARVenrock Healthcare Capital Partners II, L.P. SC 13G on Whitehawk Therapeutics, Inc.